OpenAI flags Beijing-backed Zhipu AI as a prime rival

OpenAI flags Beijing-backed Zhipu AI as a prime rival

The Zhipu AI logo is seen displayed on a smartphone screen. Sopa Images | Lightrocket | Getty Images OpenAI is putting a spotlight on an under-the-radar artificial intelligence startup that it believes is on the “front line” of China’s race to lead the world in AI — and its not DeepSeek.  In a blog post … Read more

Unbelievable £1.3bn theme park constructed to rival Disneyland deserted and left to rot

Unbelievable £1.3bn theme park constructed to rival Disneyland deserted and left to rot

Mirapolis was created to rival Disneyland Paris when it opened in 1987, but within four years, the ambitious project became one of the country’s most infamous failures as it now lies abandoned Amy Jones Lifestyle & Features Writer and Kris Boratyn 07:00, 21 Jun 2025 The amusement park in France, Mirapolis, was built to rival … Read more

Starlink rival Eutelsat pops 22% as France backs capital elevate

Starlink rival Eutelsat pops 22% as France backs capital elevate

A ground network of satellites at the headquarters of Eutelsat Madeira Unipessoal Lda in Canial, Madeira, Portugal, on Saturday, March 8, 2025. Bloomberg | Bloomberg | Getty Images Eutelsat shares popped on Friday morning, after the European satellite operator announced a 1.35 billion euro ($1.55 billion) capital raise led by the French state and bcaked by … Read more

Microsoft-backed AI lab Mistral debuts reasoning mannequin to rival OpenAI

Microsoft-backed AI lab Mistral debuts reasoning mannequin to rival OpenAI

French founder of artificial intelligence startup Mistral AI, Arthur Mensch, attends the Viva Technology show at Parc des Expositions Porte de Versailles in Paris, France, on May 22, 2024. Chesnot | Getty Images Entertainment | Getty Images French artificial intelligence firm Mistral is on Tuesday launching its first reasoning model to compete with rival options … Read more

FDA approves Merck RSV shot for infants to rival Sanofi AstraZeneca

FDA approves Merck RSV shot for infants to rival Sanofi AstraZeneca

The Food and Drug Administration on Monday approved Merck’s shot designed to protect infants from respiratory syncytial virus during their first season of the virus, bringing to market a rival to a similar treatment from Sanofi and AstraZeneca. The decision will allow the company to launch the drug, which will be marketed as Enflonsia, ahead … Read more